Role of miR-15a/miR-16-1 and the TP53 Axis in Regulating Telomerase Expression in Chronic Lymphocytic Leukemia

Haematologica - Italy
doi 10.3324/haematol.2016.157669
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

miR-15a; miR-16-1

Science-Business eXchange
2008English

Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181

Cancer Research
Cancer ResearchOncology
2006English

MiR-15a/miR-16-1 Expression Inversely Correlates With Cyclin D1 Levels in Men1 Pituitary NETs

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Diagnostic and Prognostic Value of Serum miR-15a and miR-16-1 Expression Among Egyptian Patients With Prostate Cancer

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

miR-15a and miR-16-1 Downregulate CCND1 and Induce Apoptosis and Cell Cycle Arrest in Osteosarcoma

Oncology Reports
MedicineCancer ResearchOncology
2012English

NDRG2 mRNA Levels and miR-28-5p and miR-650 Activity in Chronic Lymphocytic Leukemia

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Fatty Acid Synthase Is a Primary Target of MiR-15a and MiR-16-1 in Breast Cancer

Oncotarget
Oncology
2016English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Ebv-Mir-Bhrf1-1 Targets P53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy